A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

NCT07105215 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: RC278

Sponsor

RemeGen Co., Ltd.